Comera Life Financials
This page shows Comera Life (CMRA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
This is a development-stage business where external financing, not product revenue, has been carrying operations and liquidity.
By FY2022, operating cash burn reached$9.8M against only$447K of cash, so the loss profile translated almost directly into funding pressure rather than staying on paper. The liquidity swing from 6.5x current coverage in FY2021 to 0.6x in FY2022 shows how quickly that financing cushion was consumed.
Even with a high reported gross margin of
The balance sheet ended FY2022 with negative equity of
Financial Health Signals
We are recalculating Comera Life's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.
Comera Life scores -24.18, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($6K) relative to total liabilities ($10.0M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Comera Life passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, Comera Life generates $0.54 in operating cash flow (-$9.8M OCF vs -$18.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Comera Life earns $-587.0 in operating income for every $1 of interest expense (-$12.0M vs $20K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Comera Life generated $633K in revenue in fiscal year 2022. This represents an increase of 97.9% from the prior year.
Comera Life's EBITDA was -$11.9M in fiscal year 2022, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 117.9% from the prior year.
Comera Life reported -$18.0M in net income in fiscal year 2022. This represents a decrease of 230.2% from the prior year.
Cash & Balance Sheet
Comera Life generated -$9.8M in free cash flow in fiscal year 2022, representing cash available after capex. This represents a decrease of 151.3% from the prior year.
Comera Life held $447K in cash against $0 in long-term debt as of fiscal year 2022.
Comera Life had 17M shares outstanding in fiscal year 2022.
Margins & Returns
Comera Life's gross margin was 66.8% in fiscal year 2022, indicating the percentage of revenue retained after direct costs. This is up 17.1 percentage points from the prior year.
Comera Life's operating margin was -1890.7% in fiscal year 2022, reflecting core business profitability. This is down 159.9 percentage points from the prior year.
Comera Life's net profit margin was -2843.8% in fiscal year 2022, showing the share of revenue converted to profit. This is down 1139.2 percentage points from the prior year.
Capital Allocation
Comera Life invested $1.7M in research and development in fiscal year 2022. This represents a decrease of 0.7% from the prior year.
Comera Life invested $29K in capex in fiscal year 2022, funding long-term assets and infrastructure. This represents a decrease of 79.9% from the prior year.
CMRA Income Statement
| Metric | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $136K-56.7% | $315K-19.8% | $393K+151.7% | $156K-33.5% | $235K+60.1% | $147K+53.9% | $95K | N/A |
| Cost of Revenue | $42K-25.1% | $56K-51.9% | $117K+131.4% | $50K-17.4% | $61K+11.8% | $55K+22.5% | $45K | N/A |
| Gross Profit | $94K-63.6% | $259K-6.3% | $276K+161.3% | $106K-39.2% | $174K+88.7% | $92K+81.4% | $51K | N/A |
| R&D Expenses | $366K+55.3% | $236K-31.4% | $344K-29.8% | $489K+23.9% | $395K+7.1% | $369K-24.4% | $487K | N/A |
| SG&A Expenses | $1.9M+25.4% | $1.5M-38.2% | $2.4M-7.3% | $2.6M+13.4% | $2.3M-37.4% | $3.7M+83.3% | $2.0M | N/A |
| Operating Income | -$2.2M-45.7% | -$1.5M+40.8% | -$2.5M+16.9% | -$3.0M-18.7% | -$2.5M+36.2% | -$4.0M-62.0% | -$2.5M | N/A |
| Interest Expense | $6K+50.0% | $4K-47.8% | $8K | N/A | $13K | N/A | $77 | N/A |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | N/A |
| Net Income | -$2.2M-52.6% | -$1.4M+43.1% | -$2.5M+16.2% | -$3.0M+3.7% | -$3.1M+66.1% | -$9.1M-215.5% | -$2.9M | N/A |
| EPS (Diluted) | $-0.10-25.0% | $-0.08+38.5% | $-0.13 | N/A | $-0.20+82.5% | $-1.14+71.6% | $-4.01 | N/A |
CMRA Balance Sheet
| Metric | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.1M+31.3% | $2.3M-22.0% | $3.0M-19.5% | $3.7M-24.5% | $4.9M-19.5% | $6.1M | N/A | $7.4M |
| Current Assets | $2.6M+44.2% | $1.8M-24.2% | $2.4M-21.4% | $3.1M-28.6% | $4.3M-20.7% | $5.4M | N/A | $6.8M |
| Cash & Equivalents | $1.8M+271.2% | $476K-69.0% | $1.5M+244.5% | $447K-83.3% | $2.7M-46.0% | $4.9M+27.8% | $3.9M-40.7% | $6.5M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | $250K | N/A | $34K-88.3% | $294K+193.8% | $100K | N/A | $0 |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $7.3M-16.1% | $8.7M+5.2% | $8.3M-17.1% | $10.0M+19.2% | $8.4M+5.6% | $7.9M | N/A | $22.1M |
| Current Liabilities | $2.9M-25.8% | $4.0M+17.8% | $3.4M-33.7% | $5.1M+47.5% | $3.4M+35.9% | $2.5M | N/A | $1.0M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$4.2M+33.5% | -$6.4M-20.6% | -$5.3M+15.7% | -$6.2M-82.2% | -$3.4M-91.3% | -$1.8M+89.5% | -$17.1M-16.4% | -$14.7M |
| Retained Earnings | -$41.0M-5.6% | -$38.8M-3.8% | -$37.4M-7.1% | -$34.9M-9.3% | -$31.9M-10.7% | -$28.9M | N/A | -$16.9M |
CMRA Cash Flow Statement
| Metric | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.9M-92.7% | -$994K+47.9% | -$1.9M-3.1% | -$1.8M+22.7% | -$2.4M+10.3% | -$2.7M+7.1% | -$2.9M-79.0% | -$1.6M |
| Capital Expenditures | $0-100.0% | $6K-93.6% | $88K | $0-100.0% | $25K | N/A | N/A | $131K |
| Free Cash Flow | -$1.9M-91.6% | -$999K+49.9% | -$2.0M-7.9% | -$1.8M+23.5% | -$2.4M | N/A | N/A | -$1.7M |
| Investing Cash Flow | $0+100.0% | -$6K+93.6% | -$88K | $0+100.0% | -$25K | N/A | N/A | -$131K |
| Financing Cash Flow | $3.2M+5172.3% | -$63K-104.0% | $1.6M+39.8% | $1.1M+678.9% | $145K-96.1% | $3.7M+1582.7% | $223K | $0 |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
CMRA Financial Ratios
| Metric | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.2%-13.0pp | 82.2%+11.9pp | 70.3%+2.6pp | 67.7%-6.3pp | 74.1%+11.2pp | 62.8%+9.5pp | 53.3% | N/A |
| Operating Margin | -1582.5%-1112.6pp | -469.8%+166.6pp | -636.4%+1291.0pp | -1927.4%-848.2pp | -1079.3%+1628.4pp | -2707.7%-135.0pp | -2572.7% | N/A |
| Net Margin | -1580.0%-1132.0pp | -448.1%+183.5pp | -631.5%+1266.1pp | -1897.6%-587.9pp | -1309.7%+4882.3pp | -6192.0%-3171.7pp | -3020.3% | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -70.1%-9.8pp | -60.3%+22.4pp | -82.7%-3.2pp | -79.5%-17.2pp | -62.3%+85.9pp | -148.2% | N/A | N/A |
| Current Ratio | 0.90+0.4 | 0.46-0.3 | 0.72+0.1 | 0.61-0.6 | 1.25-0.9 | 2.14 | N/A | 6.49 |
| Debt-to-Equity | -1.73-0.4 | -1.37+0.2 | -1.57+0.0 | -1.60+0.8 | -2.44+2.0 | -4.42 | N/A | -1.51 |
| FCF Margin | -1404.2%-1087.0pp | -317.1%+190.4pp | -507.5%+676.0pp | -1183.5%-155.7pp | -1027.8% | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$6.2M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.61), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Comera Life's annual revenue?
Comera Life (CMRA) reported $633K in total revenue for fiscal year 2022. This represents a 97.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Comera Life's revenue growing?
Comera Life (CMRA) revenue grew by 97.9% year-over-year, from $320K to $633K in fiscal year 2022.
Is Comera Life profitable?
No, Comera Life (CMRA) reported a net income of -$18.0M in fiscal year 2022, with a net profit margin of -2843.8%.
What is Comera Life's EBITDA?
Comera Life (CMRA) had EBITDA of -$11.9M in fiscal year 2022, measuring earnings before interest, taxes, depreciation, and amortization.
What is Comera Life's gross margin?
Comera Life (CMRA) had a gross margin of 66.8% in fiscal year 2022, indicating the percentage of revenue retained after direct costs of goods sold.
What is Comera Life's operating margin?
Comera Life (CMRA) had an operating margin of -1890.7% in fiscal year 2022, reflecting the profitability of core business operations before interest and taxes.
What is Comera Life's net profit margin?
Comera Life (CMRA) had a net profit margin of -2843.8% in fiscal year 2022, representing the share of revenue converted into profit after all expenses.
What is Comera Life's free cash flow?
Comera Life (CMRA) generated -$9.8M in free cash flow during fiscal year 2022. This represents a -151.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Comera Life's operating cash flow?
Comera Life (CMRA) generated -$9.8M in operating cash flow during fiscal year 2022, representing cash generated from core business activities.
What are Comera Life's total assets?
Comera Life (CMRA) had $3.7M in total assets as of fiscal year 2022, including both current and long-term assets.
What are Comera Life's capital expenditures?
Comera Life (CMRA) invested $29K in capital expenditures during fiscal year 2022, funding long-term assets and infrastructure.
How much does Comera Life spend on research and development?
Comera Life (CMRA) invested $1.7M in research and development during fiscal year 2022.
What is Comera Life's current ratio?
Comera Life (CMRA) had a current ratio of 0.61 as of fiscal year 2022, which is below 1.0, which may suggest potential liquidity concerns.
What is Comera Life's debt-to-equity ratio?
Comera Life (CMRA) had a debt-to-equity ratio of -1.60 as of fiscal year 2022, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Comera Life's return on assets (ROA)?
Comera Life (CMRA) had a return on assets of -483.1% for fiscal year 2022, measuring how efficiently the company uses its assets to generate profit.
What is Comera Life's cash runway?
Based on fiscal year 2022 data, Comera Life (CMRA) had $447K in cash against an annual operating cash burn of $9.8M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Comera Life's debt-to-equity ratio negative or unusual?
Comera Life (CMRA) has negative shareholder equity of -$6.2M as of fiscal year 2022, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Comera Life's Altman Z-Score?
Comera Life (CMRA) has an Altman Z-Score of -24.18, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Comera Life's Piotroski F-Score?
Comera Life (CMRA) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Comera Life's earnings high quality?
Comera Life (CMRA) has an earnings quality ratio of 0.54x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Comera Life cover its interest payments?
Comera Life (CMRA) has an interest coverage ratio of -587.0x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.